SCOTTISH MEDICINES CONSORTIUM
NHS SCOTLAND
Providing advice about the status of all newly licensed medicines
Advice Page
Drug Details
| Drug Number: | 526/09 |
| Drug Name: | lapatinib (Tyverb) |
| Drug Manufacturer: | GlaxoSmithKline |
| BNF Category: | Malignant disease and immunosuppression |
| Submission type : | Resubmission |
| Date Advice Issued: | 12.07.10 |
| Indication: | For the treatment of patients with advanced or metastatic breast cancer |
Read the briefing note